ES8503689A1 - "procedimiento para la obtencion de compuestos farmacologicamente activos por aislamiento de los factores individuales del complejo antibiotico teicomicina a2". - Google Patents

"procedimiento para la obtencion de compuestos farmacologicamente activos por aislamiento de los factores individuales del complejo antibiotico teicomicina a2".

Info

Publication number
ES8503689A1
ES8503689A1 ES522941A ES522941A ES8503689A1 ES 8503689 A1 ES8503689 A1 ES 8503689A1 ES 522941 A ES522941 A ES 522941A ES 522941 A ES522941 A ES 522941A ES 8503689 A1 ES8503689 A1 ES 8503689A1
Authority
ES
Spain
Prior art keywords
teichomycin
factor
teicomicina
isolation
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522941A
Other languages
English (en)
Spanish (es)
Other versions
ES522941A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of ES522941A0 publication Critical patent/ES522941A0/es
Publication of ES8503689A1 publication Critical patent/ES8503689A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES522941A 1982-06-08 1983-06-01 "procedimiento para la obtencion de compuestos farmacologicamente activos por aislamiento de los factores individuales del complejo antibiotico teicomicina a2". Expired ES8503689A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08

Publications (2)

Publication Number Publication Date
ES522941A0 ES522941A0 (es) 1985-04-01
ES8503689A1 true ES8503689A1 (es) 1985-04-01

Family

ID=10530888

Family Applications (2)

Application Number Title Priority Date Filing Date
ES522941A Expired ES8503689A1 (es) 1982-06-08 1983-06-01 "procedimiento para la obtencion de compuestos farmacologicamente activos por aislamiento de los factores individuales del complejo antibiotico teicomicina a2".
ES536770A Granted ES536770A0 (es) 1982-06-08 1984-10-15 Procedimiento para la obtencion del factor 2 de la teicomicina a2

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES536770A Granted ES536770A0 (es) 1982-06-08 1984-10-15 Procedimiento para la obtencion del factor 2 de la teicomicina a2

Country Status (32)

Country Link
US (1) US4542018A (OSRAM)
JP (5) JPS591423A (OSRAM)
KR (1) KR900008246B1 (OSRAM)
AU (1) AU560966B2 (OSRAM)
BE (1) BE896993A (OSRAM)
BG (1) BG60529B2 (OSRAM)
CA (1) CA1208204A (OSRAM)
CH (1) CH657139A5 (OSRAM)
DE (1) DE3320342A1 (OSRAM)
DK (1) DK159117C (OSRAM)
ES (2) ES8503689A1 (OSRAM)
FI (1) FI73697C (OSRAM)
FR (1) FR2528050B1 (OSRAM)
GB (1) GB2121401B (OSRAM)
GR (1) GR78267B (OSRAM)
HK (1) HK55887A (OSRAM)
HU (1) HU193538B (OSRAM)
IE (1) IE55025B1 (OSRAM)
IL (1) IL68819A0 (OSRAM)
IT (1) IT1212085B (OSRAM)
LU (1) LU84853A1 (OSRAM)
MY (1) MY8700002A (OSRAM)
NL (1) NL8301980A (OSRAM)
NO (1) NO159104C (OSRAM)
NZ (1) NZ204480A (OSRAM)
PH (1) PH19533A (OSRAM)
PT (1) PT76831B (OSRAM)
SE (1) SE459094B (OSRAM)
SG (1) SG70686G (OSRAM)
SU (1) SU1318170A3 (OSRAM)
UA (1) UA6025A1 (OSRAM)
ZA (1) ZA833607B (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
AU8865191A (en) * 1990-12-05 1992-07-08 Gruppo Lepetit S.P.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
PT912604E (pt) 1996-04-23 2002-05-31 Biosearch Italia Spa Processo quimico melhorado para a preparacao de derivados amida do antibiotico a 40926
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US6900175B2 (en) * 2002-11-18 2005-05-31 Vicuron Pharmaceuticals Inc. Methods of administering dalbavancin for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
NZ204480A (en) 1986-04-11
LU84853A1 (fr) 1984-03-07
PH19533A (en) 1986-05-20
BG60529B2 (bg) 1995-07-28
DE3320342C2 (OSRAM) 1991-07-11
JPS591423A (ja) 1984-01-06
ZA833607B (en) 1984-03-28
JPH02288887A (ja) 1990-11-28
GB2121401B (en) 1985-09-18
ES8506748A1 (es) 1985-08-16
GB8315003D0 (en) 1983-07-06
JPH0415237B2 (OSRAM) 1992-03-17
DK245883D0 (da) 1983-05-31
DK159117C (da) 1991-02-11
NO159104B (no) 1988-08-22
JPH0415238B2 (OSRAM) 1992-03-17
FI73697B (fi) 1987-07-31
SE459094B (sv) 1989-06-05
KR900008246B1 (ko) 1990-11-06
GR78267B (OSRAM) 1984-09-26
NL8301980A (nl) 1984-01-02
SU1318170A3 (ru) 1987-06-15
SE8303211L (sv) 1983-12-09
JPH0517236B2 (OSRAM) 1993-03-08
IE831329L (en) 1983-12-08
FR2528050A1 (fr) 1983-12-09
FI831660L (fi) 1983-12-09
UA6025A1 (uk) 1994-12-29
SE8303211D0 (sv) 1983-06-07
JPH0517237B2 (OSRAM) 1993-03-08
NO831754L (no) 1983-12-09
BE896993A (fr) 1983-12-07
SG70686G (en) 1987-07-03
FI73697C (fi) 1987-11-09
PT76831A (en) 1983-07-01
HU193538B (en) 1987-10-28
ES522941A0 (es) 1985-04-01
HK55887A (en) 1987-08-07
IT8321432A0 (it) 1983-06-02
FI831660A0 (fi) 1983-05-12
GB2121401A (en) 1983-12-21
DK159117B (da) 1990-09-03
KR840005170A (ko) 1984-11-05
DK245883A (da) 1983-12-09
JPH02291278A (ja) 1990-12-03
IE55025B1 (en) 1990-04-25
IT1212085B (it) 1989-11-08
CH657139A5 (fr) 1986-08-15
MY8700002A (en) 1987-12-31
DE3320342A1 (de) 1983-12-08
ES536770A0 (es) 1985-08-16
US4542018A (en) 1985-09-17
JPH02288888A (ja) 1990-11-28
CA1208204A (en) 1986-07-22
AU560966B2 (en) 1987-04-30
AU1496883A (en) 1983-12-15
IL68819A0 (en) 1983-09-30
NO159104C (no) 1988-11-30
PT76831B (en) 1986-04-09
FR2528050B1 (fr) 1987-03-20
JPH0224278B2 (OSRAM) 1990-05-29
JPH02291279A (ja) 1990-12-03

Similar Documents

Publication Publication Date Title
ES8503689A1 (es) "procedimiento para la obtencion de compuestos farmacologicamente activos por aislamiento de los factores individuales del complejo antibiotico teicomicina a2".
NO931153D0 (no) Vannloeselige comptothecin-analoger fremgangsmaater og metoder
ATE38672T1 (de) 7-oxabicycloheptan aminosubstituierte prostaglandinaehnliche verbindungen.
ES2131496T3 (es) Mejoras relativas a derivados glicopeptidicos.
FI852522A0 (fi) Menetelmä tymopentiinianalogien valmistamiseksi
DK232483D0 (da) Fremgangsmade til fremstilling af ws 6049-forbindelser
ES8403157A1 (es) Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral.
DK455088D0 (da) Syntetiske receptoranaloger
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
FR2564106B1 (fr) Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix.
KR950700684A (ko) 시클릭 항-종양 촉진제 화합물, 그의 조성물, 제조 방법 및 용도(Cyclic Anti-Tumor Promoter Compounds, Compositions and Methods for Production and Use)
DK218388A (da) Aktivt princip isoleret fra hajvaev
SE8404334L (sv) 16-fluoro-16,17-didehydro-prostanoider och forfarande for deras framstellning
DK229984A (da) 4-oxothiazolidin-2-yliden-acetamidderivater
ES2068425T3 (es) Procedimiento para la preparacion de compuestos de 2-aril-5-(trifluormetil)pirrol insecticidas, acaricidas y nematicidas.
DE3462257D1 (en) 4-amino-3-imidozolin-2-on and (2-methoxy-2-imino-ethyl) urea, their preparation and application
NO942032L (no) Fremgangsmåter for fremstilling av rensede löselige type B og A menneskeblodplate-avledete vekstfaktor-reseprofragmenter
ES8404183A1 (es) Un procedimiento para la preparacion de composiciones farmaceuticas orales de acido propionhidroxamico.
BG36346A3 (bg) Метод за получаване на имидазо/4,5,-в/-пиридини и -пиримидини
DK159847C (da) Salte af 5-cyanopyridin-2-diazohydroxid
SE8205568D0 (sv) Diastereomers
JPS5251394A (en) Preparation of 6-n-substituted-aminopurines
ES530508A0 (es) Un metodo de preparar 2'-desoxioxanosina
IT8222589A0 (it) Colture perfezionate per tessuti cellulari.
NO864088D0 (no) Mitogene peptider.